CYP1A1 and hypertensive disorder: Considering activation of the AHR/CYP1A1 axis induces vasoconstriction [26], resveratrol suppress renal CYP1A1 expression might, at least in part, contribute to its beneficial effects against TCDD-induced hypertension.